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stroma or bile duct communication: two case
reports and a review of the literature
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Minoru Kitago1, Taizo Hibi1, Yuta Abe1, Hiroshi Yagi1, Akihiro Tanimoto3, Minoru Tanabe4, Michiie Sakamaoto2
and Yuko Kitagawa1Abstract
We report two cases of cystic neoplasm of the liver with mucinous epithelium in which both ovarian-like stroma and
bile duct communication were absent. The first case was a 41-year-old woman. She underwent right trisegmentectomy
due to a multilocular cystic lesion, 15 cm in diameter, with papillary nodular components in the medial segment and
right lobe. Histologically, arborizing papillae were seen in the papillary lesion. The constituent neoplastic cells had
sufficient cytoarchitectural atypia to be classified as high-grade dysplasia. The second case was a 60-year-old woman.
She underwent left lobectomy due to a unilocular cystic lesion, 17 cm in diameter, in the left lobe. Histologically, the
cyst wall was lined by low columnar epithelia with slight cellular atypia. In both cases, neither ovarian-like stroma nor
bile duct communications were found throughout the resected specimen. According to the most recent World Health
Organization (WHO) classification in 2010, cystic tumors of the liver with mucinous epithelium are classified as mucinous
cystic neoplasms when ovarian-like stromata are found, and as intraductal papillary neoplasm of bile duct when bile
duct communication exists. Therefore, we diagnosed the cystic tumors as ‘biliary cystadenoma’ according to the past
WHO classification scheme from 2000. We believe that the combined absence of both ovarian-like stroma and bile duct
communication is possible in mucinous cystic tumors of the liver. Herein, we have described the clinicopathologic
features of the two cases and reviewed past cases in the literature.
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papillary neoplasm of bile ductBackground
The disease entity ‘biliary cystadenoma/adenocarcinoma’
was described in the World Health Organization (WHO)
Classification of Tumors 3rd Edition, published in 2000
[1]. The disease is rare, usually slow-growing, occurs pre-
dominantly in middle-aged women, and is characterized
by multilocular cystic tumors filled with mucinous fluid.
Microscopically, a single layer of mucin-secreting cells
lines the cyst wall. However, the diagnostic criteria for bil-
iary cystadenoma/cystadenocarcinoma have been vague.
Cases of biliary cystadenoma/cystadenocarcinoma lacking
ovarian-like stroma (OS) have been reported, suggesting* Correspondence: masa02114@yahoo.co.jp
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unless otherwise stated.that the diagnosis of cystadenoma or cystadenocarcinoma
was not necessarily made based on the presence of OS
[2,3]. Given this confusion, the latest WHO Classification
of Tumors for the digestive system, published in 2010,
proposed that the disease entity previously designated as
‘biliary cystadenoma/adenocarcinoma’ should instead be
classified as either mucinous cystic neoplasm (MCN) or
intraductal papillary neoplasm of bile duct (IPN-B) de-
pending on the presence of OS and bile duct communica-
tion (BDC), respectively [4]. Herein, we report two cases
of cystic neoplasm of the liver with mucinous epithelium
in which both OS and BDC were absent, and which could
not be clearly classified as either MCN or IPN-B. We en-
countered the first case after publication of the WHO
classification system in 2010. The encounter with this case
led us to survey our past cases that had been diagnosed asLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ing to the WHO classification system in 2000. We patho-
logically re-examined specimens of the past cases and
identified another case without either OS or BDC. We re-
port this past case as the second of the two case reports.
We also reviewed past cases in the literature and discuss
problems regarding the diagnostic criteria for cystic neo-
plasms of the liver in the absence of OS and BDC.
Case presentation
Case 1
A 41-year-old Japanese woman had undergone laparo-
scopic deroofing due to a liver cyst in the right lobe inFigure 1 Preoperative image findings (case 1). (A) Computed tomograp
is seen in the medial segment and right lobe. The lesion is multilocular, co
side of the umbilical portion of the portal vein (umbilical portion is indicate
diffusion-weighted magnetic resonance imaging. T2-weighted image show
section presented here, three separated lesions are seen (indicated by a, b,
contained multiple papillary nodular components with enhancement. Cystic l
lesion (b) has a papillary nodular component in its posterior side (indicated by
A diffusion-weighted image showed diffusion restriction in the nodular comp2009 at another hospital. After the operation, the cystic le-
sion could still be confirmed by ultrasonography, and the
patient subsequently underwent follow-up for blood ana-
lysis and ultrasonography every six months for three years.
Recent ultrasonography revealed an increase in the size of
the cystic lesion. The patient was referred to our hospital
for further examination in 2012. Since the patient had a
medical history of iodine hypersensitivity, we could not
employ contrast-enhanced computed tomography and
endoscopic retrograde cholangiography (ERC) for the ex-
aminations. Computed tomography without contrast en-
hancement revealed a multilocular cystic lesion, 15 cm in
diameter, in the medial segment and right lobe (Figure 1A).hy without contrast enhancement. A cystic lesion, 15 cm in diameter,
nsisting of several separated lesions. The tumor is adjacent to the right
d by arrow heads). (B) T2-weighted, (C) contrast-enhanced, and (D)
ed the cystic lesion in the medial segment and right lobe. On the
and c). Contrast enhancement showed that each separated lesion
esion (a) contains a tiny nodule inside (indicated by an arrowhead), cystic
arrowheads), and lesion (c) was filled with papillary nodular components.
onents in the lesion of (b) and (c) (indicated by arrows).
Figure 2 (See legend on next page.)
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Figure 2 Macroscopic and microscopic findings of the resected specimen (case 1). (A) The gross appearance of the tumor. Macroscopically,
the whole lesion was 130 x 90 mm in size in the resected specimen. The image of the lesion is illustrated as an inset in the lower right. The
letters (a), (b), and (c) denote separated cystic lesions and correspond to those in Figure 1B. The medial side of the cyst wall of cyst (b) and the
septum between the cysts (a) and (b) are lost in the specimen. There is a papillary mass in the posterior side of lesion (b) (indicated by arrows).
The lesion (c) is filled with solid components. (B) A loupe observation of the solid component surrounded by a white line in (A) (hematoxylin
and eosin). A papillary nodular mass (indicated by arrowheads) is seen inside of the cyst wall. (C) A magnified observation of the point encircled
in (B) (x20, hematoxylin and eosin). Arborizing papillae with thin-walled vessel are seen. The lesion is lined by multilayers of cuboidal to columnar
cells with abundant eosinophilic cytoplasm forming intraepithelial lumina (some of the lumens are indicated by asterisks (*)). The tumor cells had
sufficient cytoarchitectural atypia to be classified as having high-grade dysplasia. (D) (E) A magnified (x20) image of the cyst wall (hematoxylin
and eosin in (D)) and immunohistochemical staining for progesterone receptor in (E). The cyst wall is indicated by a double arrow. Tumor
components consisting of multilayer cuboidal to columnar cells (upper side of the cystic wall in the picture, inside of the tumor) and normal hepatocytes
(lower side of the cystic wall in the picture, outside of the tumor) are seen. No ovarian-like stromata were seen throughout the cyst walls.
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vealed the cystic lesion (Figure 1B). Contrast-enhanced
magnetic resonance imaging showed that the lesion con-
tained multiple papillary nodular components with en-
hancement (Figure 1C). Diffusion-weighted magnetic
resonance imaging showed diffusion restriction in the
nodular components (Figure 1D). Ultrasonography with
Sonazoid™ (Daiichi-Sankyo, Tokyo, Japan) revealed an en-
hancement corresponding to the solid component that
was evident by diffusion-weighted magnetic resonance im-
aging. No evidence of metastases to the lymph nodes or
other organs was found in the preoperative images. The
extrahepatic bile duct was not dilated in the images. As-
partate aminotransferase, alanine aminotransferase, alka-
line phosphatase, gamma-glutamyltransferase, albumin,
and total bilirubin levels were all within normal limits. Ser-
ology tests were negative for hepatitis B and C viruses.
The serum levels of carcinoembryonic antigen and CA19-
9 were within normal limits. According to the pathology
report from the patient’s previous hospital, the resected
cyst wall was lined by simple columnar epithelium with
papillary change, no malignant changes were evident, and
OS was absent in the specimen. The diagnosis in the re-
port was cystadenoma. From the information contained in
the previous report and the findings from imaging at our
hospital, we could not diagnose the cystic lesion as either
MCN or IPN-B, but we suspected that the solid compo-
nent in the cystic lesion had a malignancy and per-
formed right trisegmentectomy. Ten days after surgery,
she developed bile leakage and underwent endoscopic
retrograde nasobiliary drainage. The postoperative course
was otherwise uneventful and the patient was discharged
on postoperative day 64. The patient is still alive at 19
months postoperatively.
Macroscopically, the cystic lesion, 130 by 90 mm in size,
was multilocular and had a solid lesion inside (Figure 2A)
with a large amount of mucin. Whole liver specimens
were cut into 5 to 10 mm thick pieces, which were then
sliced into 5-μm sections. Histologically, the tumor showed
papillary nodular growth in several cysts (Figure 2B). The
tumor had complex and arborizing papillae with thin-walled vessels. The papillae or cysts were lined by multi-
layers of cuboidal to columnar cells with abundant eosino-
philic cytoplasm forming intraepithelial lumina. The
neoplastic cells had round, large, and fairly uniform nuclei
with single prominent nucleoli. There was no evidence of
stromal invasion; however, the tumor had sufficient cyto-
architectural atypia to be classified as having high-grade
dysplasia (Figure 2C). All sections were examined carefully,
but no OS were seen throughout the cyst walls (Figure 2D,
E). BDC was also not evident throughout the specimens.
Immunohistochemical analyses revealed that neoplastic
cells were positive for MUC-5 AC and MUC-6 but not for
MUC-1, MUC-2, or CDX-2. Histological and immunohis-
tochemical findings both suggested that the tumor could be
classified histologically as the oncocytic type. Since both OS
and BDC were not detected in the specimen and ERC was
not employed in this case, we diagnosed the cystic tumor
as biliary cystadenoma, based on the WHO classification
system from 2000 [1].
Case 2
A 60-year-old Japanese woman came to our hospital in
2004 complaining of abdominal discomfort. Computed
tomography with contrast enhancement revealed a uni-
locular cystic lesion, 17 cm in diameter, in the left lobe of
the liver preoperatively. No nodular components were
identified in the cystic lesion and no contrast enhance-
ment was observed in the cyst wall. T2-weighted magnetic
resonance imaging revealed septum-like structures in the
cystic lesion (Figure 3). Ultrasonography also showed
floating septum-like structures in the lesion. ERC was not
scheduled. She had been afebrile before the operation. The
white blood cell count and levels of C-reactive protein,
carcinoembryonic antigen, and CA19-9 were within nor-
mal limits. Based on this preoperative information, the
cystic lesion was diagnosed as a simple cyst or biliary
cystadenoma and the attending surgeon scheduled an op-
eration for cyst fenestration or left lobectomy. At the be-
ginning of the operation, the surgeon punctured the cyst
and found that the fluid was turbid brown. Although the
total bilirubin concentration in the fluid was 2.1 mg/dl
Figure 3 Preoperative findings of T2-weighted magnetic
resonance imaging (case 2). A cystic lesion, 17 cm in diameter,
occupies almost half of the abdominal cavity on the slice shown.
Septum-like structures are seen in the lesion.
Figure 4 Microscopic findings of the resected specimen
(hematoxylin and eosin, x20) (case 2). The cyst wall is lined by
low columnar epithelia with slight cellular atypia. No ovarian-like
stromata were seen throughout the cyst walls.
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nant cells, the surgeon worried about the possibility of in-
fection in the lesion and its spread to the abdominal
cavity, so a left lobectomy was performed. The postopera-
tive course was uneventful and the patient was discharged
on postoperative day 16. The patient remains alive at nine
years postoperatively.
Macroscopically, the cystic lesion, 200 by 150 mm in
size, was unilocular, had no solid lesion inside, and did not
contain mucin. Whole liver specimens were cut into 5 to
10 mm thick pieces, which were then sliced into 5-μm
sections. Histologically, the cyst wall was lined by low col-
umnar epithelia with slight cellular atypia (Figure 4). All
sections were examined at the time of surgery, but no OS
or BDC were seen throughout the specimens. We diag-
nosed the cystic tumor as biliary cystadenoma based on
the WHO classification system from 2000. We carefully
re-examined the whole specimens again and confirmed
that there were no OS or BDC throughout the specimens.
Discussion
We encountered a case of cystic neoplasm of the liver in
which both OS and BDC could not be pathologically con-
firmed (case 1). According to the most recent WHO clas-
sification, cystic neoplasms of the liver are classified as
MCN with OS and without BDC, and as IPN-B with BDC
and without OS [4]; therefore, it is difficult to clearly clas-
sify the case as either of these two disease entities. We as-
sumed that the combined absence of both OS and BDC
would be possible in mucinous cystic tumors of the liver,
and we surveyed other cases of cystic neoplasm of the liver
with mucinous epithelium that we had seen over the past
10 years at our hospital. There were three cases of cystic
neoplasm of the liver with mucinous epithelium excludingthe first case. They were diagnosed as biliary cystade-
noma in two cases and biliary cystadenocarcinoma in
one case, according to the WHO classification system
in 2000 [1]. We pathologically re-examined specimens
from these three cases; we confirmed the presence of
OS and absence of BDC in two cases (one case of biliary
cystadenoma and one case of biliary cystadenocarci-
noma), and we found a case without either OS or BDC
(case 2). We believe that there may be potential cases of
cystic neoplasm of the liver with mucinous epithelium
in which both OS and BDC are absent.
In a search of the PubMed database, we found 18 arti-
cles that addressed cystic IPN-B [5-22]. The 18 articles re-
ported a total of 193 cases of cystic IPN-B in which BDC
was confirmed in 120 cases, unclear in 11 cases, and not
described in 62 cases. The 11 cases in which BDC was un-
clear were reported in three articles [5-7]. Kubota and
associates reported 119 cases of IPN-B in their multi-
institutional retrospective study and found seven cases of
possible IPN-B without either OS or BDC even after their
re-examination of the original sections in 2013 [5]. In
2011, Lim and associates surveyed 87 cases with surgically
resected IPN-B and identified two cases in which both OS
and BDC were not detected [6]. In the same year, Mano
and associates reported two cases of cystic tumors of the
liver without OS and BDC as possible MCN [7]. Combin-
ing the past 11 cases and our two cases, there have been
13 published cases of cystic neoplasm of the liver without
OS and BDC.
We assume that there are two possibilities for cases with
absence of both OS and BDC. One possibility is a failure to
prove the presence of BDC during the diagnostic process.
Presence of BDC is usually confirmed by preoperative ERC.
However, BDC is often unclear in preoperative imaging
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with mucus, contrast medium may not flow into the
communicating bile duct. There may be cases of iodine
hypersensitivity as in the present case. Even in patho-
logical examinations, it is possible that BDC cannot be
detected throughout the specimen though it may in fact
exist. It has been noted that intraoperative injection of
contrast medium into the specimen may be technically
difficult because resected liver specimens have many
transected bile duct branches at the margins [7]. An-
other possibility is that all or some of the 13 cases of
cystic neoplasm of the liver without both OS and BDC
consist of a disease entity that is neither IPN-B nor
MCN. Since Kubota and colleagues [5] provided little
information regarding the clinicopathological features
of subjects in their study, we summarized the features
of four cases previously reported by Lim [6] and Mano
[7] and two previous cases from our hospital (Table 1).
The mean age was 57.8 years and the cohort consisted
of three males and three females. The mean diameter
was 13.5 cm and the diameter was greater than 10 cm
in five of six cases. The tumor location was the left lobe
in four cases, central bi-segment in one case, and right
lobe in one case. There were two cases of malignancy
and four cases of low- and/or high-grade dysplasia. It
remains to be determined whether the features of
middle- to old-age, no gender deviation, relatively large
size, left lobe dominance, and malignant potential rep-
resent a disease entity that is neither IPN-B nor MCN.
Further assessment of additional cases of cystic neo-
plasm of the liver without OS and BDC is needed to
clarify the features of this potential disease entity.
Conclusion
We presented two cases of cystic neoplasm of the liver
without OS and BDC and identified four similar contro-
versial cases from the PubMed database. Considering
these six cases, we conclude that it is difficult to clearly
classify cystic neoplasms of the liver with mucinous epi-
thelium into MCN or IPN-B based only on clinical or
histological findings. It is important to recognize that
the most recent WHO classification is based on histo-
logical classification alone, which is probably unsatisfac-
tory. We agree with the prevailing consensus that the
presence of OS or BDC has become an important differ-
ential diagnostic criterion for IPN-B and MCN, but look
forward to a better means for diagnosing cystic neo-
plasm of the liver in cases where both OS and BDC are
not detected during preoperative examination and ana-
lysis of resected specimens. We hope that this case pres-
entation and literature review serve as a stimulus for
further investigation to establish a method to accurately
diagnose cystic neoplasms of the liver with absence of
OS and BDC.Consent
Written informed consent was obtained from the pa-
tients for publication of the case report and any accom-
panying images.
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